ID: ALA544506

Max Phase: Preclinical

Molecular Formula: C9H10Br2ClN

Molecular Weight: 290.99

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.NCC(=C(Br)Br)c1ccccc1

Standard InChI:  InChI=1S/C9H9Br2N.ClH/c10-9(11)8(6-12)7-4-2-1-3-5-7;/h1-5H,6,12H2;1H

Standard InChI Key:  PZVXEBAOEHHORD-UHFFFAOYSA-N

Associated Targets(non-human)

Monoamine oxidase 439 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 290.99Molecular Weight (Monoisotopic): 288.9102AlogP: 3.10#Rotatable Bonds: 2
Polar Surface Area: 26.02Molecular Species: BASEHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.12CX LogP: 2.68CX LogD: 0.97
Aromatic Rings: 1Heavy Atoms: 12QED Weighted: 0.89Np Likeness Score: -0.03

References

1. McDonald IA, Lacoste JM, Bey P, Palfreyman MG, Zreika M..  (1985)  Enzyme-activated irreversible inhibitors of monoamine oxidase: phenylallylamine structure-activity relationships.,  28  (2): [PMID:3968682] [10.1021/jm00380a007]

Source